Guangdong, China

Shouting Wu

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Zhuhai United Laboratories Co., Ltd.. Active years: 2025.


% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shouting Wu: Innovator in JAK Inhibitor Research

Introduction

Shouting Wu is a prominent inventor based in Guangdong, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of drugs for treating JAK kinase-related diseases. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Shouting Wu holds a patent for the "Use of JAK inhibitors in preparation of drugs for treating JAK kinase-related diseases." This patent discloses the use of a JAK inhibitor [1,2,4]-triazolo-[1,5-a]pyridine compound in the preparation of drugs aimed at treating autoimmune, inflammatory, or allergic diseases, as well as conditions such as transplant rejection. The JAK inhibitor has demonstrated good efficacy in animal model tests for these diseases. He has 1 patent to his name, reflecting his innovative contributions to the field.

Career Highlights

Wu is currently associated with Zhuhai United Laboratories Co., Ltd., where he continues to work on groundbreaking research. His role in the company allows him to collaborate with other talented professionals in the pharmaceutical industry, further enhancing his contributions to medical advancements.

Collaborations

Some of his notable coworkers include Shuai Wang and Degang Wang. Their collaborative efforts contribute to the innovative environment at Zhuhai United Laboratories Co., Ltd.

Conclusion

Shouting Wu is a dedicated inventor whose work in JAK inhibitors is paving the way for new treatments for various diseases. His patent and ongoing research highlight his commitment to improving healthcare through innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…